Lionsgate Studios (LION) director Harkey reports equity awards and RSUs

Rhea-AI Filing Summary

Lionsgate Studios Corp. director John D. Harkey, Jr. reported changes in his holdings of the company’s common shares. On 11/28/2025, he acquired 20,107 common shares at $0 as part of his annual director equity award, increasing his directly held common shares to 192,647. The same day, he also received 8,713 common shares at $7.46 as payment of director fees in stock, bringing his holdings to 201,360 common shares.

The footnotes explain that these holdings include restricted share units that convert into common shares upon vesting. They include 20,066 restricted share units scheduled to vest on November 29, 2025 and 20,107 restricted share units scheduled to vest on November 28, 2026. These equity awards represent a mix of compensation and long-term incentives linked to future service and vesting dates.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HARKEY JOHN D JR

(Last) (First) (Middle)

LIONSGATE

2700 COLORADO AVENUE

(Street)

SANTA MONICA CA 90404

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lionsgate Studios Corp. [ LION ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	11/28/2025		A		20,107(1)	A	$0	192,647(2)	D
Common Shares	11/28/2025		A		8,713(3)	A	$7.46	201,360(2)	D
Common Shares	11/29/2025		F		0	D	$7.46	201,360(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual director equity award.

2. Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,066 restricted share units that are scheduled to vest on November 29, 2025; and (ii) 20,107 restricted share units that are scheduled to vest on November 28, 2026.

3. Director fees paid in common shares.

4. Amount includes 20,107 restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer, that are scheduled to vest on November 28, 2026.

Remarks:

	John D. Harkey, Jr. (By Adrian Kuzycz by Power of Attorney)	12/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Lionsgate Studios Corp. (LION) report for John D. Harkey, Jr.?

The filing shows that director John D. Harkey, Jr. acquired Lionsgate Studios Corp. common shares through equity awards and director fee payments in stock on 11/28/2025.

How many Lionsgate Studios (LION) shares did the director receive as an equity award?

On 11/28/2025, the director received 20,107 common shares at $0 as his annual director equity award.

How were director fees paid in Lionsgate Studios Corp. (LION) stock?

The director received 8,713 common shares at $7.46 on 11/28/2025, which are identified as director fees paid in common shares.

What is the director’s beneficial ownership in Lionsgate Studios (LION) after these transactions?

Following the reported transactions, the director beneficially owns 201,360 common shares of Lionsgate Studios Corp. directly.

What restricted share units (RSUs) are disclosed for Lionsgate Studios (LION) in this filing?

The filing notes 20,066 restricted share units scheduled to vest on November 29, 2025 and 20,107 restricted share units scheduled to vest on November 28, 2026, each payable in an equal number of common shares.

What is the role of the reporting person at Lionsgate Studios Corp. (LION)?

The reporting person, John D. Harkey, Jr., is identified as a Director of Lionsgate Studios Corp.